Duration of expression and activity of sleeping beauty transposase in mouse liver following hydrodynamic DNA delivery

Molecular Therapy

Volumn 18, Issue 10, 2010, Pages 1796-1802

  Bell, Jason B ^a,b   Aronovich, Elena L ^a,b   Schreifels, Jeffrey M ^a,b   Beadnell, Thomas C ^a,b   Hackett, Perry B ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; LUCIFERASE; MESSENGER RNA; SLEEPING BEAUTY 11; TRANSPOSASE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE CASSETTE; GENE EXPRESSION; GENE LOSS; GENE TARGETING; HYDRODYNAMICS; IN VIVO GENE TRANSFER; LIVER; MOUSE; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REPORTER GENE; TRANSGENE; TRANSPOSON;

MAMMALIA; MUS;

EID: 77957552575     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2010.152     Document Type: Article

References (47)

1. Aiuti, A and Roncarolo, MG (2009). Ten years of gene therapy for primary immune deficiencies. Hematology Am Soc Hematol Educ Program: 682-689.
2. Ott, MG, Schmidt, M, Schwarzwaelder, K, Stein, S, Siler, U, Koehl, U et al. (2006). Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med 12: 401-409.
3. Aiuti, A, Cattaneo, F, Galimberti, S, Benninghoff, U, Cassani, B, Callegaro, L et al. (2009). Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med 360: 447-458.
4. Cartier, N, Hacein-Bey-Abina, S, Bartholomae, CC, Veres, G, Schmidt, M, Kutschera, I et al. (2009). Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 326: 818-823.
5. Manno, CS, Pierce, GF, Arruda, VR, Glader, B, Ragni, M, Rasko, JJ et al. (2006). Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med 12: 342-347.
6. Manno, CS, Chew, AJ, Hutchison, S, Larson, PJ, Herzog, RW, Arruda, VR et al. (2003). AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood 101: 2963-2972.
7. Simonelli, F, Maguire, AM, Testa, F, Pierce, EA, Mingozzi, F, Bennicelli, JL et al. (2010). Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration. Mol Ther 18: 643-650.
8. Hacein-Bey-Abina, S, Garrigue, A, Wang, GP, Soulier, J, Lim, A, Morillon, E et al. (2008). Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J Clin Invest 118: 3132-3142.
9. Kustikova, OS, Schiedlmeier, B, Brugman, MH, Stahlhut, M, Bartels, S, Li, Z et al. (2009). Cell-intrinsic and vector-related properties cooperate to determine the incidence and consequences of insertional mutagenesis. Mol Ther 17: 1537-1547.
10. Fehse, B and Roeder, I (2008). Insertional mutagenesis and clonal dominance: biological and statistical considerations. Gene Ther 15: 143-153.
11. Ivics, Z, Hackett, PB, Plasterk, RH and Izsvak, Z (1997). Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 91: 501-510.
12. Yant, SR, Wu, X, Huang, Y, Garrison, B, Burgess, SM and Kay, MA (2005). Highresolution genome-wide mapping of transposon integration in mammals. Mol Cell Biol 25: 2085-2094.
13. Geurts, AM, Hackett, CS, Bell, JB, Bergemann, TL, Collier, LS, Carlson, CM et al. (2006). Structure-based prediction of insertion-site preferences of transposons into chromosomes. Nucleic Acids Res 34: 2803-2811.
14. Berry, C, Hannenhalli, S, Leipzig, J and Bushman, FD (2006). Selection of target sites for mobile DNA integration in the human genome. PLoS Comput Biol 2: e157.
15. Henikoff, S (1998). Conspiracy of silence among repeated transgenes. Bioessays 20: 532-535.
16. Hammond, SM, Bernstein, E, Beach, D and Hannon, GJ (2000). An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 404: 293-296.
17. Hackett, PB, Largaespada, DA and Cooper, LJ (2010). A transposon and transposase system for human application. Mol Ther 18: 674-683.
18. Geurts, AM, Yang, Y, Clark, KJ, Liu, G, Cui, Z, Dupuy, AJ et al. (2003). Gene transfer into genomes of human cells by the Sleeping Beauty transposon system. Mol Ther 8: 108-117.
19. Hackett, PB (2007). Integrating DNA vectors for gene therapy. Mol Ther 15: 10-12.
20. Atkinson, H and Chalmers, R (2010). Delivering the goods: viral and non-viral gene therapy systems and the inherent limits on cargo DNA and internal sequences. Genetica 138: 485-498.
21. Aronovich, EL, Bell, JB, Belur, LR, Gunther, R, Koniar, B, Erickson, DC et al. (2007). Prolonged expression of a lysosomal enzyme in mouse liver after Sleeping Beauty transposon-mediated gene delivery: implications for non-viral gene therapy of mucopolysaccharidoses. J Gene Med 9: 403-415.
22. Aronovich, EL, Bell, JB, Khan, SA, Belur, LR, Gunther, R, Koniar, B et al. (2009). Systemic correction of storage disease in MPS I NOD/SCID mice using the Sleeping Beauty transposon system. Mol Ther 17: 1136-1144.
23. Williams, DA (2008). Sleeping Beauty vector system moves toward human trials in the United States. Mol Ther 16: 1515-1516.
24. Carlson, CM and Largaespada, DA (2005). Insertional mutagenesis in mice: new perspectives and tools. Nat Rev Genet 6: 568-580.
25. Yant, SR, Meuse, L, Chiu, W, Ivics, Z, Izsvak, Z and Kay, MA (2000). Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system. Nat Genet 25: 35-41.
26. Mates, L, Chuah, MK, Belay, E, Jerchow, B, Manoj, N, Acosta-Sanchez, A et al. (2009). Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates. Nat Genet 41: 753-761.
27. Liu, F, Song, Y and Liu, D (1999). Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther 6: 1258-1266.
28. Zhang, G, Budker, V and Wolff, JA (1999). High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum Gene Ther 10: 1735-1737.
29. Al-Dosari, MS, Knapp, JE and Liu, D (2005). Hydrodynamic delivery. Adv Genet 54: 65-82.
30. Herweijer, H and Wolff, JA (2003). Progress and prospects: naked DNA gene transfer and therapy. Gene Ther 10: 453-458.
31. Bell, JB, Podetz-Pedersen, KM, Aronovich, EL, Belur, LR, McIvor, RS and Hackett, PB (2007). Preferential delivery of the Sleeping Beauty transposon system to livers of mice by hydrodynamic injection. Nat Protoc 2: 3153-3165.
32. Podetz-Pedersen, KM, Bell, JB, Steele, TW, Wilber, A, Shier, WT, Belur, LR et al. (2010). Gene expression in lung and liver after intravenous infusion of polyethylenimine complexes of Sleeping Beauty transposons. Hum Gene Ther 21: 210-220.
33. Mikkelsen, JG, Yant, SR, Meuse, L, Huang, Z, Xu, H and Kay, MA (2003). Helper?Independent Sleeping Beauty transposon-transposase vectors for efficient nonviral gene delivery and persistent gene expression in vivo. Mol Ther 8: 654-665.
34. Dupuy, AJ, Akagi, K, Largaespada, DA, Copeland, NG and Jenkins, NA (2005). Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system. Nature 436: 221-226. (Pubitemid 41021267)
35. Suda, T, Gao, X, Stolz, DB and Liu, D (2007). Structural impact of hydrodynamic injection on mouse liver. Gene Ther 14: 129-137.
36. Liu, G, Aronovich, EL, Cui, Z, Whitley, CB and Hackett, PB (2004). Excision of Sleeping Beauty transposons: parameters and applications to gene therapy. J Gene Med 6: 574-583.
37. Ponder, KP, Gupta, S, Leland, F, Darlington, G, Finegold, M, DeMayo, J et al. (1991). Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation. Proc Natl Acad Sci USA 88: 1217-1221.
38. Kmiec, Z (2001). Cooperation of liver cells in health and disease. Adv Anat Embryol Cell Biol 161: III-XIII, 1.
39. Rossmanith, W, Chabicovsky, M, Herkner, K and Schulte-Hermann, R (2002). Cellular gene dose and kinetics of gene expression in mouse livers transfected by high-volume tail-vein injection of naked DNA. DNA Cell Biol 21: 847-853.
40. Liu, ZJ, Moav, B, Faras, AJ, Guise, KS, Kapuscinski, AR and Hackett, PB (1990). Functional analysis of elements affecting expression of the β-actin gene of carp. Mol Cell Biol 10: 3432-3440.
41. Yew, NS, Przybylska, M, Ziegler, RJ, Liu, D and Cheng, SH (2001). High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter. Mol Ther 4: 75-82.
42. Gill, DR, Smyth, SE, Goddard, CA, Pringle, IA, Higgins, CF, Colledge, WH et al. (2001). Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1α promoter. Gene Ther 8: 1539-1546.
43. Ochiai, H, Fujimuro, M, Yokosawa, H, Harashima, H and Kamiya, H (2007). Transient activation of transgene expression by hydrodynamics-based injection may cause rapid decrease in plasmid DNA expression. Gene Ther 14: 1152-1159.
44. Cui, Z, Geurts, AM, Liu, G, Kaufman, CD and Hackett, PB (2002). Structure-function analysis of the inverted terminal repeats of the Sleeping Beauty transposon. J Mol Biol 318: 1221-1235.
45. Rahrmann, EP, Collier, LS, Knutson, TP, Doyal, ME, Kuslak, SL, Green, LE et al. (2009). Identification of PDE4D as a proliferation promoting factor in prostate cancer using a Sleeping Beauty transposon-based somatic mutagenesis screen. Cancer Res 69: 4388-4397.
46. Wild, R, Ramakrishnan, S, Sedgewick, J and Griffioen, AW (2000). Quantitative assessment of angiogenesis and tumor vessel architecture by computer-assisted digital image analysis: effects of VEGF-toxin conjugate on tumor microvessel density. Microvasc Res 59: 368-376.
47. Wolfe JH, Sands MS (1996). Murine mucopolysaccharidosis type VII: a model system for somatic gene therapy for the central nervous system. In: Protocols for Gene Transfer in Neurosciences: Towards Gene Therapy of Neurological Disorders. John Wiley and Sons: Essex, England, pp. 263-274.